Detection of mammaglogin A in blood from breast cancer patients, before and after treatment, using a one-tube nested PCR protocol. Association with the absence of tumor estrogen receptors

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1429-1433

  Ceballos, María P ^a   Zumoffen, Carlos ^a   Massa, Estefanía ^a   Cipulli, Germán ^b   Funes, Carlos Capitaine ^b   Gil, Alfonso Benitez ^c   Morales, Cristian ^d   Tozzini, Roberto ^b   Ghersevich, Sergio ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Mastology service of the Centenario Hospital   (Argentina)

^c Mastology service of the Provincial Hospital ^*  (Argentina)

^d Mastology service of the Eva Perón Hospital   (Argentina)

Author keywords

Breast cancer; Circulating tumor cells; Mammaglobin A; Tumor prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; MAMMAGLOGIN A; MEMBRANE PROTEIN; RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BREAST CARCINOMA; CANCER PATIENT; CANCER SURGERY; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MAMMAGLOBIN A; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 81555219225     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.08.1140     Document Type: Article

References (34)

1. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006, 13:1033-1067.
2. Welch D.R. Do we need to redefine a cancer metastasis and staging definitions?. Breast Dis 2006, 26:3-12.
3. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
4. Ring A., Smith I.E., Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol 2004, 5:79-88.
5. Jiang W.G., Martin T.A., Mansel R.E. Molecular detection of micro-metastasis in breast cancer. Crit Rev Oncol Hematol 2002, 43:13-31.
6. Cristofanilli M., Hayes D.F., Budd G.T., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23:1420-1430.
7. Müller V., Stahmann N., Riethdorf S., et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005, 11:3678-3685.
8. Gargano G., Agnese V., Calò V., et al. Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol 2006, 17:vii41-vii45.
9. Grünewald K., Haun M., Urbanek M., et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest 2000, 80:1071-1077.
10. Suchy B., Austrup F., Driesel G., et al. Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett 2000, 158:171-178.
11. Silva A.L., Diamond J., Silva M.R., Passos-Coelho J.L. Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues. Breast Cancer Res Treat 2001, 66:59-66.
12. Zach O., Kasparu H., Krieger O., Hehenwarter W., Girschikofsky M., Lutz D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 1999, 17:2015-2019.
13. Lin Y.C., Wu Chou Y.H., Liao I.C., Cheng A.J. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers. Cancer Lett 2003, 191:93-99.
14. Watson M.A., Fleming T.P. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996, 56:860-865.
15. Fleming T.P., Watson M.A. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 2000, 923:78-89.
16. Corradini P., Voena C., Astolfi M., et al. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann Oncol 2001, 12:1693-1698.
17. O'Brien N., Maguire T.M., O'Donovan N., et al. Mammaglobin A: a promising marker for breast cancer. Clin Chem 2002, 48:1362-1364.
18. Harris L., Fritsche H., Mennel R., et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312.
19. Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J., et al. Thresholds for therapies: highlights of the St Gallen International Expert Concensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20:1319-1329.
20. Percoll: Methodology and Applications. Amersham Biosciences 2001, Uppsala, Sweden.
21. Sambrook J., Russel D.W. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 3rd edn.
22. Robbins P., Pinder S., de Klerk N., et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 1995, 26:873-879.
23. Williams S.L., Birdsong G.G., Cohen C., Siddiqui M. Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations. Int J Clin Exp Pathol 2009, 2:476-480.
24. Silva A.L., Tomé M.J., Correia A.E., Passos-Coelho J.L. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products. Ann Oncol 2002, 13:422-429.
25. Ballestrero A., Garuti A., Bertolotto M., et al. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer 2005, 92:1948-1952.
26. Ferro P., Franceschini M.C., Bacigalupo B., et al. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors. Anticancer Res 2010, 30:2377-2382.
27. Roncella S., Ferro P., Bacigalupo B., et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J Exp Clin Cancer Res 2005, 24:265-271.
28. Bölke E., Orth K., Gerber P.A., et al. Gene expression of circulating tumour cells in breast cancer patients. Eur J Med Res 2009, 14:426-432.
29. Markou A., Strati A., Malamos N., Georgoulias V., Lianidou E.S. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin Chem 2011, 57:421-430.
30. Cerveira N., Torres L., Rocha P., et al. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients. Int J Cancer 2004, 108:592-595.
31. Zehentner B.K., Persing D.H., Deme A., et al. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clin Chem 2004, 50:2069-2076.
32. Lin Y.-C., Chen S.-C., Hsueh S., et al. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer Sci 2003, 94:99-102.
33. Mikhitarian K., Martin R.H., Ruppel M.B., et al. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer 2008, 8:55.
34. Ntoulia M., Stathopoulou A., Ignatiadis M., et al. Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin Biochem 2006, 39:879-887.